T Cell 'Traffic Control' Boosts Drug Hope
Posted on: Saturday, 16 July 2005, 00:00 CDT
U.S. scientists have begun to clarify how one of the body's molecules controls the trafficking of T cells through the blood to fight infection.
The traffic control system -- composed of a fat-like compound called S1P and its receptor on T cells -- usually prevents T cells from launching harmful reactions. But when the S1P traffic cop reacts incorrectly, T cells can swamp healthy tissue.
The new research explains how a promising experimental drug treats the autoimmune disease multiple sclerosis by blocking excess S1P action, said Dr. Edward Goetzl of the University of California at San Francisco and Dr. Hugh Rosen, of the Scripps Research Institute.
The research shows the promise of similar strategies to prevent rejection of transplanted organs and tissues without compromising essential immune defenses, according to the study published in a special issue of Nature Reviews Immunology.
Source: United Press International
Related Articles
- President Bush Again Rejects Calls on Stem-Cell Research
- John Kerry Hails Stem Cell Research
- Op-Ed; AS YOU WERE SAYING . . . Intrinsic Value of Human Life Must Trump Stem-Cell Research
- Kerry on Radio Pushes Stem Cell Research
- Hollywood Pushing for Stem Cell Research
- Pentagon Gives Swedes Money for Stem Cell Research
- Charleston, W.Va., University Hosts Forum on Ethics of Stem Cell Research
- New Jersey First State to Fund Stem Cell Research
- U.S. Quickly Losing Edge in Stem Cell Research
- Ethical dilemmas in stem-cell research
 |
 |
User Comments (0)
RSS Feeds